Terms: = Pancreatic cancer AND KLK2, P20151, 3817, ENSG00000167751, MGC12201, hK2, KLK2A2 AND Treatment
8 results:
1. Glycolytic enzyme hk2 promotes PD-L1 expression and breast cancer cell immune evasion.
Lin J; Fang W; Xiang Z; Wang Q; Cheng H; Chen S; Fang J; Liu J; Wang Q; Lu Z; Ma L
Front Immunol; 2023; 14():1189953. PubMed ID: 37377974
[TBL] [Abstract] [Full Text] [Related]
2. UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/hk2 and glycolysis.
Zhao L; Kang M; Liu X; Wang Z; Wang Y; Chen H; Liu W; Liu S; Li B; Li C; Chang A; Tang B
J Exp Clin Cancer Res; 2022 Nov; 41(1):330. PubMed ID: 36419136
[TBL] [Abstract] [Full Text] [Related]
3. Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα.
Guo D; Tong Y; Jiang X; Meng Y; Jiang H; Du L; Wu Q; Li S; Luo S; Li M; Xiao L; He H; He X; Yu Q; Fang J; Lu Z
Cell Metab; 2022 Sep; 34(9):1312-1324.e6. PubMed ID: 36007522
[TBL] [Abstract] [Full Text] [Related]
4. Hyperglycemia Enhances Immunosuppression and Aerobic Glycolysis of pancreatic cancer Through Upregulating Bmi1-UPF1-hk2 Pathway.
Wu S; Zhang H; Gao C; Chen J; Li H; Meng Z; Bai J; Shen Q; Wu H; Yin T
Cell Mol Gastroenterol Hepatol; 2022; 14(5):1146-1165. PubMed ID: 35863742
[TBL] [Abstract] [Full Text] [Related]
5. Ikarugamycin inhibits pancreatic cancer cell glycolysis by targeting hexokinase 2.
Jiang SH; Dong FY; Da LT; Yang XM; Wang XX; Weng JY; Feng L; Zhu LL; Zhang YL; Zhang ZG; Sun YW; Li J; Xu MJ
FASEB J; 2020 Mar; 34(3):3943-3955. PubMed ID: 31944405
[TBL] [Abstract] [Full Text] [Related]
6. Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer.
Fan K; Fan Z; Cheng H; Huang Q; Yang C; Jin K; Luo G; Yu X; Liu C
Cancer Med; 2019 Oct; 8(13):5903-5915. PubMed ID: 31426130
[TBL] [Abstract] [Full Text] [Related]
7. Paracrine HGF/c-MET enhances the stem cell-like potential and glycolysis of pancreatic cancer cells via activation of YAP/HIF-1α.
Yan B; Jiang Z; Cheng L; Chen K; Zhou C; Sun L; Qian W; Li J; Cao J; Xu Q; Ma Q; Lei J
Exp Cell Res; 2018 Oct; 371(1):63-71. PubMed ID: 30056064
[TBL] [Abstract] [Full Text] [Related]
8. Novel inhibitory activity for serine protease inhibitor Kazal type-3 (Spink3) on human recombinant kallikreins.
Assis DM; Zalazar L; Juliano MA; De Castro R; Cesari A
Protein Pept Lett; 2013 Oct; 20(10):1098-107. PubMed ID: 23590280
[TBL] [Abstract] [Full Text] [Related]
